![](https://investorshub.advfn.com/uicon/522650.png?cb=1464431304)
Monday, July 24, 2017 5:20:04 PM
To come out in the public and say IPCI did not submit proof that Rexista is abuse deterrent is absurd.
The FDA document confirms the Reuter's reporting. IPCI did not submit any human studies to support the abuse deterrent label. All the ADF data was extraction studies. This might qualify for IV abuse ADF label but not a label for snorting or chewing. Go back and look at every drug that got the chewing and snorting labels. Every one submitted "Drug Liking" **human** studies. IPCI only submitted in vitro data, apparently due to "Philosophical differences with the FDA."
I bet Purdue's lawyers loved Della Penna's statement today. He basically said we use the exact same ADF tech as OxyContin, and therefore we expect to get an ADF label based on Purdue's HAL studies. Sorry, Dude, not how any of this works.
Best in class at what??? No human studies to support that. Like I said, maybe it is Best to Chew While In Class, but certainly not Best In Class.
Well you placed your life on credit and your lovin' days are done,
The checks you signed with love and kisses later come back signed insufficient funds.
Funkadelic - Can You Get To That
Maggot Brain, 1971
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM